Voltaren Gel Approval History
FDA Approved: Yes (First approved October 17, 2007)
Brand name: Voltaren Gel
Generic name: diclofenac sodium
Dosage form: Topical Gel
Company: Novartis AG
Treatment for: Osteoarthritis
Voltaren Gel (diclofenac sodium) is a topical gel non-steroidal anti-inflammatory (NSAID) medication indicated for the pain of osteoarthritis in joints amenable to topical treatment, such as the knees and those of the hands.
Development History and FDA Approval Process for Voltaren Gel
|Oct 22, 2007||Voltaren Gel Receives US Regulatory Approval as the First ApprovedTopical Prescription Treatment for Pain Associated withOsteoarthritis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.